Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $3.35 Million - $4.16 Million
-25,400 Closed
0 $0
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $3 Million - $3.41 Million
-28,200 Reduced 52.61%
25,400 $2.74 Million
Q1 2021

Apr 01, 2021

BUY
$102.3 - $112.62 $153,450 - $168,930
1,500 Added 2.88%
53,600 $5.8 Million
Q1 2020

Apr 02, 2020

SELL
$64.5 - $97.79 $258,000 - $391,160
-4,000 Reduced 7.13%
52,100 $3.97 Million
Q2 2019

Jul 02, 2019

BUY
$65.7 - $83.98 $3.69 Million - $4.71 Million
56,100 New
56,100 $4.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pensionfund Dsm Netherlands Portfolio

Follow Pensionfund Dsm Netherlands and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionfund Dsm Netherlands, based on Form 13F filings with the SEC.

News

Stay updated on Pensionfund Dsm Netherlands with notifications on news.